Delcath (DCTH) 2026 Earnings Outlook: What Investors Need
Biotech earnings season shines a spotlight on Delcath Systems. This guide breaks down the 2026 earnings outlook, key ...
Learn the scenarios where index funds outperform target date funds, with emphasis on fees, control, and asset allocation flexibility.
26,348 articlesBiotech earnings season shines a spotlight on Delcath Systems. This guide breaks down the 2026 earnings outlook, key ...
A six-state AI pilot for Original Medicare is delaying and denying care for certain procedures, drawing bipartisan sc...
A potential 50% tariff on Canadian goods could lift construction costs and tighten loan terms. If negotiations fail, ...
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
An AI-driven forecast linked to Sam Altman points to a sharp Bitcoin rally by year-end 2026, with specific price band...
SanDisk has enjoyed a dramatic rally, but traders are wrestling with whether the rally can run further as memory cycl...
Oil weakness adds pressure on Chevron as analysts weigh earnings visibility and cash returns. A rising risk of a drop...
Daré (DARE) has a developing pipeline and a tight cash runway. This article breaks down what the Q4 2025 earnings cal...
A troubling case shows how unauthorized enrollment in life insurance can unfold. Learn how the scheme worked, red fla...
As the CLARITY Act advances toward a full Senate vote in June, XRP traders weigh potential price moves. We asked grok...
Applied Materials just ripped higher again, sparking a profit-taking debate as the stock taps fresh highs. This repor...
Washington moves to allow scissor stairs in multifamily buildings, a change lenders say could reduce upfront costs an...